ESAB Q2 2026 Earnings: Record Sales Came With Margin Pressure

ESAB Corporation (NYSE: ESAB) reported fiscal Q2 2026 net sales of $807.6 million, up 12.9% year over year, while GAAP diluted EPS from continuing operations fell to $0.54 from $1.12. Core adjusted EBITDA increased 8.0% to $149.6 million, but its margin declined 90 basis points to 19.5% as price-cost neutrality and targeted commercial investments limited operating leverage. Both segments returned to core organic growth, although the company’s higher full-year sales outlook was driven by a larger expected M&A contribution rather than a stronger organic forecast.

Core earnings data

For the quarter ended July 3, 2026, reported sales increased by about $92 million and core organic sales grew 2.5%. Gross profit rose faster than sales, but higher selling, general and administrative expenses and restructuring charges pushed GAAP operating income lower.

The difference between GAAP and adjusted results was substantial. Core adjusted EBITDA increased, while core adjusted net income and EPS declined slightly and GAAP earnings fell more sharply.

ESAB’s core non-GAAP measures exclude its Russia business. Core organic sales also exclude acquisitions and foreign-currency translation.

Segment performance

Both the Americas and EMEA & APAC segments generated core organic growth. Core adjusted EBITDA increased in both segments, but margin performance diverged: the Americas posted a modest improvement, while EMEA & APAC experienced a meaningful decline.

Management cited particular strength in North America and Asia, resilient conditions in Europe and a challenging environment in the Middle East. The EMEA & APAC margin contraction indicates that higher segment EBITDA did not translate into comparable operating leverage.

Acquisition and operating costs widened the gap between sales and GAAP earnings

ESAB’s record sales did not flow through to GAAP operating profit because expenses grew faster than gross profit. Selling, general and administrative expense increased to $210.2 million from $155.6 million, while restructuring and related charges rose to $18.3 million from $1.4 million. Together, those increases more than absorbed the $41.2 million improvement in gross profit.

Acquisition, amortization and related pretax charges increased to $41.3 million from $21.6 million. This included $24.8 million of transaction, diligence and integration expenses and $16.5 million of intangible amortization and acquired-inventory fair-value adjustments. Interest expense and other items also rose to $30.6 million from $21.0 million, adding further pressure below the operating line.

The adjusted results show that the underlying business remained profitable, but not without pressure. ESAB attributed the 90-basis-point decline in core adjusted EBITDA margin to temporary price-cost neutrality and targeted commercial investments intended to support equipment growth.

2026 guidance

ESAB raised its full-year core sales and core adjusted EBITDA guidance. The higher sales outlook was driven by the expected M&A contribution increasing to approximately 9%, while the organic growth and foreign-exchange assumptions were unchanged. The company’s latest core adjusted EPS outlook is $5.40 to $5.50.

The update coincided with ESAB closing the Eddyfi acquisition one month ahead of schedule. Because the organic forecast did not change, execution and integration of acquired businesses will be important to delivering the higher total-growth target.

Management commentary

CEO Shyam Kambeyanda said ESAB expects to mitigate logistics-related inflation and higher commodity costs over the next few quarters. Management also presented Eddyfi as an expansion into higher-growth and higher-margin workflow adjacencies, while maintaining its longer-term focus on organic growth, margin expansion and debt reduction.

Risks investors should watch

• Organic growth remains moderate: Q2 core organic growth was 2.5%, and the full-year organic outlook stayed at 2% to 4%. The raised total-sales forecast therefore depends heavily on acquisitions.
• Margin recovery is not yet evident: Core adjusted EBITDA margin declined 90 basis points as price-cost conditions and commercial investment offset part of the revenue growth. The timing of management’s expected cost mitigation remains important.
• Acquisition and restructuring costs are weighing on GAAP earnings: Higher integration, amortization and restructuring charges contributed to a sharp decline in operating income and diluted EPS.
• Financing costs have increased: Interest expense rose year over year. ESAB also issued $175 million of mandatory convertible preferred stock in June with a 6.5% annual dividend, creating additional financing and potential dilution considerations.
• Regional performance is uneven: Management reported strength in North America and Asia but continued difficulty in the Middle East, while EMEA & APAC’s core adjusted EBITDA margin declined materially.

Summary

ESAB’s Q2 2026 results combined record reported sales and renewed organic growth with weaker margins and sharply lower GAAP earnings. Acquisitions supported the top line and drove the higher full-year sales outlook, but elevated operating, integration and financing costs limited profit conversion. The next key tests are whether ESAB can restore margin expansion, integrate Eddyfi effectively and deliver its acquisition-led guidance without losing momentum in the core business.